Navigation Links
Cephalon Reports Record Earnings and Raises 2010 Guidance

2010, to exclude proceeds related to the settlement of litigation in Europe ($2.1M), offset by charges related to the acquisition of Mepha ($0.2M). In 2009, to exclude charges related to the acquisition of Arana Therapeutics Limited ($0.6M).  (4) To exclude the change in fair value of the Ception contingent consideration.(5) To exclude costs related to restructurings.(6) To exclude charges incurred in exchange for license rights to certain of XOMA Ltd.’s proprietary antibody library materials.(7) To exclude imputed interest expense associated with convertible debt ($15.1M in 2010; $17.0M in 2009).(8) In 2009, to exclude $0.4M gain on foreign exchange of Australian Dollar acquisition funds.  (9) To reflect the tax effect of pre-tax adjustments at applicable tax rates and certain other tax adjustments primarily related to changes in valuation allowances and other changes in tax assets and liabilities.CEPHALON, INC. AND SUBSIDIARIESReconciliation of GAAP Net Income to Adjusted Net Income Attributable to Cephalon, Inc.(Unaudited)Nine Months EndedSeptember 30,20102009GAAP NET INCOME ATTRIBUTABLE TO CEPHALON, INC.

332,129 $
246,069 Cost of sales adjustments24,225


(1)Research and development adjustments2,690


(2)Selling, general and administrative adjustments9,581


(3)Change in fair value of contingent consideration adjustment,314

(4)- Restructuring charges7,638


(5)In-process research and development adjustments- 46,118

(6)Interest expense adjustment50,072


(7)Other (income) expense adjustment,567


(8)Arana noncontrolling interest adjustments- (819)

(9)Income tax adjustment(64,293)


(10)*Noncontrolling Interest adjustments:Other revenues(31)30 Research and development ,377 25,519 Selling, general and administrative3,462 7,373 Interest income(7)

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
2. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
3. Cephalon Completes Acquisition of Arana Therapeutics
4. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
7. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
8. Cephalons New Product Launches Pace Record 2008 Sales
9. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
10. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
11. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Post Your Comments:
(Date:8/28/2014)... a Florida State University research team has led to ... emit white light, and convert photon energy directly to ... butterfly. , Biwu Ma, associate professor in the Department ... of Engineering, created the molecule in a lab about ... his creation has many other unique capabilities. , For ...
(Date:8/28/2014)... PrimeSource Building Products, Inc., a leading ... to support their communication needs with the ... conferencing platform GlobalMeet powered by SoundConnect. The solution ... SoundConnect delivers award winning “results driven” business class ... be utilizing GlobalMeet powered by SoundConnect ...
(Date:8/27/2014)... 27, 2014 Green & Grow Inc. ... B funding and secured Otter Capital as a significant ... accelerate commercialization of GGI’s Agriplier™ technology, building on recent ... , “Since our first meeting, we have been impressed ... product space,” said Alan Sobba, President and CEO of ...
(Date:8/27/2014)... 2014   MSC , a healthcare performance improvement ... the appointment of Mary Beth Loesch to ... of experience preparing companies for rapid growth and market ... President of Corporate Development and Healthcare. In that role, ... as well as corporate strategy and marketing. Previously, Loesch ...
Breaking Biology Technology:Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2PrimeSource Chooses SoundConnect as Collaboration Provider 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3MSC names Mary Beth Loesch President and CEO 2
... , NEW YORK, June 15 NeoStem, Inc. (NYSE ... pre-disease collection, processing and long-term storage of adult stem ... signed an exclusive 10-year agreement with Enhance BioMedical Holdings ... Collection and Treatment Network using NeoStem,s proprietary adult stem ...
... , ... announces new facility which will add capacity, additional capabilities to growing laboratory in order to ... ... new facility which will more than triple the company,s previous capacity and will accommodate projected ...
... ... Positives , ... NY (PRWEB) June 15, 2009 -- iCardiac Technologies, Inc., a leader in advanced cardiac ... a medium sized pharmaceutical company for cardiac safety evaluation comprising multiple Thorough QT (TQT) ...
Cached Biology Technology:NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces 2NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces 3NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces 4CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business 2iCardiac Selected for Multiple Cardiac Safety Studies 2
(Date:8/28/2014)... mobile app called TX Invasives is now available from ... of Texas at Austin for identifying harmful non-native plant, ... species in the United States cause about $137 billion ... agricultural crops, clog waterways, kill native plants and more. ... app for reporting where invasive species occur, we,re more ...
(Date:8/28/2014)... an expansion of marine protected areas is needed to ... According to investigators from the Wildlife Conservation Society and ... on saving the largest numbers of species, often at ... difficult-to-replace ecological functions. , Many vital ecological ... that also are food for millions of people. ...
(Date:8/28/2014)... Access to Research Careers) Program has announced the travel ... from October 18 22, 2014 in San Diego, ... entry of students, post doctorates and scientists from underrepresented ... and to encourage the participation of young scientists at ... MARC conferred 16 awards totaling $29,600., The FASEB MARC ...
Breaking Biology News(10 mins):Mobile app makes ID of harmful plants, insects in Texas a snap 2Study finds marine protected areas inadequate for protecting fish and ocean ecology 2
... body are constantly dividing to maintain our body functions. At ... supporting components has to be faithfully duplicated to maintain the ... of Copenhagen, have developed a new technology that has revealed ... of cellular memory. The results are published in Nature ...
... urgently needs a green economic strategy to move towards ... new report published today by UCL,s Green Economy Policy ... range of academic disciplines across UCL argues that ... resource constraints mean that decisive action is urgently needed ...
... YORK, NY (February 23, 2014) Columbia University Medical ... of the hippocampus known as CA2 is essential for ... another of the same species. A better grasp of ... and treating disorders characterized by altered social behaviors, such ...
Cached Biology News:New technology detect cellular memory 2Policies to green the economy must underpin UK recovery: New report 2Policies to green the economy must underpin UK recovery: New report 3Researchers pinpoint brain region essential for social memory 2Researchers pinpoint brain region essential for social memory 3
Homo sapiens CDC23 (cell division cycle 23, yeast, homolog),...
Terrific Broth, 1 kg. Mixture of casein peptone, yeast extract, K2HPO4, and KH2PO4.Used at 47 g/l for E. coli growth with higher cell densities. Category: Nucleotides & Enzymes & Biochemicals, Ultrap...
(3-[125I]iodotyrosyl26)Galanin (porcine), 925 kBq, 25 uCi. Category: IODINE LIGANDS....
Immunogen: Synthetic peptide based on the sequence: SPSSGPSLTADSMWR Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: